Dr. Reddy's Laboratories
Indian multinational pharmaceutical company
Dr. Reddy's Laboratories ▸ Facts ▸ Comments ▸ News ▸ Videos
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Aurobindo arm Eugia, Dr Reddy's & Hetero bag MPP sub-licence for generic leukemia drug NilotinibIndiaTimes - Published | |
Covid-19 vaccine: Dr Reddy's Lab to seek approval for Sputnik Light as universal booster doseIn September 2020, Dr. Reddy's partnered with Russian Direct Investment Fund to conduct clinical trials of Sputnik V and distribute vaccine in India.DNA - Published | |
Panacea Biotec to manufacture up to 25 million doses of Sputnik V vaccineThe company has entered into a "licensing and manufacturing agreement with Human Vaccine Limited Liability Company, a subsidiary of Russian Direct Investment Fund, Russia, Generium Joint Stock..IndiaTimes - Published | |
'Will strengthen commercial roll-out of Sputnik V vaccine in India in coming weeks', assures Dr Reddy's Laboratories"We will strengthen the commercial roll-out of Sputnik V in the coming weeks. Neither the ongoing soft commercial launch nor work towards its ramp-up in India has been put on hold," said Dr Reddy's..IndiaTimes - Published | |
In a first, 5 Indian pharma majors ally for Covid drug trialsIn a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 patients. The companies include Dr Reddy's..IndiaTimes - Published | |
COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in IndiaPune-based Serum Institute has also sought approval for test analysis and examination. Sputnik V is currently being manufactured by Dr Reddy's Lab.DNA - Published | |
COVID-19 vaccine: 'Sputnik V' to be available in Delhi after June 20, says KejriwalThe Delhi Government has been in talks with Dr Reddy's Laboratories for the supply of the 'Sputnik V' vaccine.DNA - Published | |
Not authorised any 3rd party to supply Sputnik V in India, legal action against unscrupulous elements: Dr Reddy’s & RDIFIndiaTimes - Published | |
Dr Reddy's developing new treatment options for Covid-19, says MDDrug major Dr Reddy's Laboratories is working on the development of new treatment options for Covid-19 patients which it aims to launch over the next few months while ensuring uninterrupted supplies of..IndiaTimes - Published | |
DRDO's 2-DG anti-Covid drug to be available by mid-June: Dr Reddy'sDr Reddy's on Wednesday said that the supply of anti-Covid drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO) is expected to commence in mid-June. In a..IndiaTimes - Published | |
Rajnath Singh to release first batch of DRDO's anti-COVID oral drug 2DG todayDeveloped by DRDO's INMAS, in collaboration with Dr Reddy's Laboratories in Hyderabad, the 2DG drug is an anti-Covid therapeutic application.DNA - Published | |
Dr Reddy's rolls out Sputnik V Covid-19 vaccine in India at around Rs 995 per doseDr Reddy’s Laboratories, the Indian partner of Russian Direct Investment Fund (RDIF), said it has commenced Sputnik V’s India rollout with the first dose being administered in Hyderabad on Friday..IndiaTimes - Published | |
As India eyes Sputnik rollout, experts question efficacy dataEven as India is gearing up to roll out Russian Covid-19 vaccine Sputnik V next week, a group of international experts has raised serious questions about the data discrepancies and substandard..IndiaTimes - Published | Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency useA potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) – has received the Drugs Controller General of India (DCGI) nod for emergency use as adjunct therapy for..IndiaTimes - Published |
